Nephrotic syndrome in adults: Diagnosis and management

American Family Physician

Volumn 80, Issue 10, 2009, Pages

  Kodner, Charles ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL MALEATE; FUROSEMIDE; METOLAZONE; POTASSIUM SPARING DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ACUTE KIDNEY FAILURE; ANTICOAGULANT THERAPY; BACTERIAL INFECTION; BLOOD EXAMINATION; CLINICAL EVALUATION; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DRUG EFFICACY; GLOMERULOSCLEROSIS; HUMAN; INFECTION RISK; KIDNEY BIOPSY; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROTEINURIA; REVIEW; SODIUM RESTRICTION; VENOUS THROMBOEMBOLISM;

EID: 73249133924     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Karnath BM, Keddis MT. The nephrotic syndrome. Hosp Physician. 2007;43(10):25-30.
2. Kitiyakara C, Kopp JB, Eggers P. Trends in the epidemiology of focal segmental glomerulosclerosis. Semin Nephrol. 2003;23(2):172-182.
3. Hull RP, Goldsmith DJ. Nephrotic syndrome in adults. BMJ. 2008;336(7654):1185-1189.
4. Cho S, Atwood JE. Peripheral edema. Am J Med. 2002;113(7):580-586.
5. Rodríguez-Iturbe B, Herrera-Acosta J, Johnson RJ. Interstitial inflammation, sodium retention, and the pathogenesis of nephrotic edema: a unifying hypothesis. Kidney Int. 2002;62(4):1379-1384.
6. Leung YY, Szeto CC, Tam LS, et al. Urine protein-to-creatinine ratio in an untimed urine collection is a reliable measure of proteinuria in lupus nephritis. Rheuma-tology (Oxford). 2007;46(4):649-652.
7. Radhakrishnan J, Appel AS, Valeri A, Appel GB. The nephrotic syndrome, lipids, and risk factors for cardiovascular disease. Am J Kidney Dis. 1993;22(1):135-142.
8. Kendall AG, Lohmann RC, Dossetor JB. Nephrotic syndrome. A hypercoagulable state. Arch Intern Med. 1971;127(6):1021-1027.
9. Kayali F, Najjar R, Aswad F, Matta F, Stein PD. Venous thromboembolism in patients hospitalized with nephrotic syndrome. Am J Med. 2008;121(3):226-230.
10. Mahmoodi BK, ten Kate MK, Waandes F, et al. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation. 2008;117(2):224-230.
11. Wu HM, Tang JL, Sha ZH, Cao L, Li YP. Interventions for preventing infection in nephrotic syndrome. Cochrane Database Syst Rev. 2004;(2):CD003964.
12. Koomans HA. Pathophysiology of acute renal failure in idiopatic nephrotic syndrome. Nephrol Dial Transplant. 2001;16(2):221-224.
13. Richards NT, Darby S, Howie AJ, Adu D, Michael J. Knowledge of renal histology alters patient management in over 40% of cases. Nephrol Dial Transplant. 1994;9(9):1255-1259.
14. Brater DC. Diuretic therapy. N Engl J Med. 1998;339(6):387-395.
15. Ruggenenti P, Mosconi L, Vendramin G, et al. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome. Am J Kidney Dis. 2000;35(3):381-391.
16. Korbet SM. Angiotensin antagonists and steroids in the treatment of focal segmental glomerulosclerosis. Semin Nephrol. 2003;23(2):219-228.
17. Stiles KP, Abbott KC, Welch PG, Yuan CM. Effects of angiotensin- converting enzyme inhibitor and steroid therapy on proteinuria in FSGS: a retrospective study in a single clinic. Clin Nephrol. 2001;56(2):89-95.
18. Dorhout Mees EJ. Does it make sense to administer albumin to the patient with nephrotic oedema?. Nephrol Dial Transplant. 1996;11(7):1224-1226.
19. Crook ED, Habeeb D, Gowdy O, Nimmagadda S, Salem M. Effects of steroids in focal segmental glomeruloscle-rosis in a predominantly African-American population. Am J Med Sci. 2005;330(1):19-24.
20. Schieppati A, Perna A, Zamora J, Giuliano GA, Braun N, Remuzzi G. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome. Cochrane Database Syst Rev. 2004;(4):CD004293.
21. Hodson EM, Willis NS, Craig JC. Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev. 2009;(3):CD001533.
22. Black DA, Rose G, Brewer DB. Controlled trial of predni-sone in adult patients with the nephrotic syndrome. Br Med J. 1970;3(5720):421-426.
23. Rashid H, Ezedum S, Morley AR, Kerr DN. Nephrotic syndrome with slight proliferative changes in the glomeruli: response to prednisone. Br Med J. 1980;281(6236):347-350.
24. Palmer SC, Nand K, Strippoli GF. Interventions for minimal change disease in adults with nephrotic syndrome. Cochrane Database Syst Rev. 2008;(1):CD001537.
25. Fan J, Li Z, Wu T, Chen H. Lipid-lowering agents for nephrotic syndrome (intervention protocol). Cochrane Database Syst Rev. 2009;(2):CD005425.
26. Kulshrestha S, Grieff M, Navaneethan SD. Interventions for preventing thrombosis in adults and children with nephrotic syndrome (intervention protocol). Cochrane Database Syst Rev. 2009;(2):CD006024.